Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.5
-219.46%
40%
—
-98.53%
40%
—
5 Years
Score2.5
Net Growth-219.46%
Net Trend40%
Net Income Consistency—
Rev Growth-98.53%
Rev Trend40%
Revenue Consistency—
Crispr Therapeutics AG fundamental performance
Between 2020 and 2025, revenue grew from $ 719K to $ 3M and net income went from -$ 348M to -$ 581M. Revenue increased in 2 of those 5 years; net income in 2.
Across Crispr Therapeutics AG's full reported history, from 2016 to 2025, revenue declined from $ 5M to $ 3M and net income went from -$ 23M to -$ 581M. Revenue increased in 50% of the years measured; net income in 40%.
Crispr Therapeutics AG currently holds a 5-year HDB Score of 2.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 53.99 | — |
1 Year2025-08-12 | $ 56.60 | -4.61% |
5 Years2021-08-12 | $ 135.39 | -60.12% |
All Time2016-10-19 | $ 14.09 | 283.18% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2016-10-19 |
|---|---|---|---|---|
| Price | $ 53.99 | $ 56.60 | $ 135.39 | $ 14.09 |
| Return | — | -4.61% | -60.12% | 283.18% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 13M | -$ 451M | $ 2.36B |
| 2025 | $ 3M | -$ 581M | $ 1.97B |
| 2024 | $ 35M | -$ 366M | $ 1.90B |
| 2023 | $ 370M | -$ 153M | $ 1.69B |
| 2022 | $ 436K | -$ 650M | $ 1.81B |
| 2021 | $ 913M | $ 377M | $ 2.37B |
| 2020 | $ 719K | -$ 348M | $ 1.69B |
| 2019 | $ 289M | $ 66M | $ 943M |
| 2018 | $ 3M | -$ 164M | $ 456M |
| 2017 | $ 40M | -$ 68M | $ 239M |
| IPO2016 | $ 5M | -$ 23M | $ 315M |
Explore beyond CRSP
You're looking at Crispr Therapeutics AG. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
